About the DADA2 Foundation


The DADA2 Foundation was founded by parents of DADA2 patients to drastically accelerate the search for a cure for the disease, increase awareness and diagnosis, and ensure that patients around the world and their medical teams have access to the most up-to-date treatments. If you or your child is a newly diagnosed patient, or if you are looking for more information about DADA2, please send us an email.

Board of Directors


Chip Chambers, M.D., Founder and President

Dr. Chambers is the former Chief of Endocrine Surgery at Vanderbilt University Medical Center in Nashville, Tennessee. He continues to hold his clinical faculty appointment at Vanderbilt, and he operates and teaches residents at the Veterans Affairs Medical Center. Dr. Chambers' two children were diagnosed with DADA2 in March 2014, just one month after the first articles describing the disease were published in the New England Journal of Medicine. He has spent the last two years making connections among clinicians treating patients with DADA2 all over the world, as well as patients, their families, and researchers studying the enzyme. 


Katherine Bell, Vice President and Secretary

Katherine Bell is the editor in chief of Barron's magazine, and the former editor of Harvard Business Review's website, HBR.org. One of her two daughters was diagnosed with DADA2 in September 2015, when she was two years old. 

Heather Peterson, Treasurer

Heather Peterson is Business Finance Officer for Senior Segment Strategic Priorites at Cigna-HealthSpring.  She has 22 years of experience in financial management and accounting, including 15 years at Ernst & Young. She is a certified public accountant in Tennessee.

Scientific Advisory Board

Roshini Abraham, Ph.D., Associate Chief of Academic Affairs, Founding Director of Diagnostic Immunology, and Professor of Pathology at Nationwide Children’s Hospital,  Columbus, Ohio

Ivona Aksentijevich, M.D., Associate Investigator, National Human Genome Research Institute at the National Institutes of Health

Blanche Alter, M.D., M.P.H., Senior Clinician in Epidemiology and Clinical Genetics, National Cancer Institute, National Institutes of Health

Bob Beall, Ph.D., Former President & CEO of the Cystic Fibrosis Foundation

Alexandre Belot, M.D., Ph.D., Department Head of Research, Pediatric Rheumatology at the University de Lyon and Hospices Civils de Lyon/ INSERM, Lyon, France

Yackov Berkun, M.D., Professor of Immunology and Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel

Paul Brogan, M.D., Ph.D., Professor of Vasculitis & Section Head for Infection, Inflammation and Rheumatology in the UCL Institute of Child Health (ICH) and Great Ormond Street Hospital, London, England

Maria Pia Cicalese, M.D., Ph.D., Staff Clinician, Pediatric Immunohematology, San Raffaele Telethon Institute for Gene Therapy San Raffaele Scientific Institute, Milan, Italy

Marco Gattorno, M.D., Senior Researcher, Center for Autoinflammatory Diseases and Immunodeficiencies at the G. Gaslini Institute at G. Gaslini Children Hospital in Genova, Italy

Larry Gibson, M.D., Consultant in Dermatology and Internal Medicine at the Mayo Clinic, Rochester, Minnesota

Marlene Haffner, M.D., M.P.H., Former Director of the Office of Orphan Products Development at the Food and Drug Administration (FDA and Adjunct Professor, Uniformed Services University School of Medicine, Bethesda, Maryland

Philip Hashkes, M.D., Staff Clinician, Pediatric Rheumatology at the Shaare Zedek Medical Center in Jerusalem, Israel

Michael Hershfield, M.D., Professor of Medicine and Biochemistry, Duke University School of Medicine, Durham, North Carolina

Jen Kanakry, M.D., bone marrow transplant physician, Bethesda, MD

Dan Kastner, M.D., Ph.D., Scientific Director, National Human Genome Research Institute, National Institutes of Health

Isabelle Kone-Paut, M.D., Professor of Rheumatology and Pediatrics, University of Paris Sud and Le Kremlin-Bicêtre University Hospital, Le Kremlin Bicêtre, France

Pui Lee, M.D., Ph.D., Instructor in Pediatrics, Department of Allergy, Immunology, and Rheumatology, Harvard Medical School and Boston Children's Hospital

Harry Malech, M.D., Chief, Laboratory Host Defenses and Chief, Genetic Immunotherapy Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health 

Isabelle Meyts, M.D., Ph.D., Professor of Pediatrics and Immunology, University Hospitals Leuven, Belgium

Alessandra Mortellaro Ph.D., Staff Scientists, San Raffaele Telethon Institute for Gene Therapy, San Raffaele Institute, Milan, Italy

Luigi Notarangelo, M.D., Chief, Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Amanda Ombrello, M.D., Associate Research Physician, Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health

Seza Ozen, M.D., Professor of Pediatrics and Pediatric Rheumatology, Hacettepe University and Children's Hospital, Ankara, Turkey

Mrinal Patnaik, MBBS, Consultantin Hematology and Oncology, Mayo Clinic, Rochester, Minnesota

Ann Reed, M.D., Chair, Department of Pediatrics and Physician-in-Chief, Duke University School of Medicine, Durham,North Carolina

Philip Roehrs, M.D., Associate Professor and Medical Director of Pediatric Bone & Marrow Transplant, Levine Children's Hospital, Charlotte, North Carolina

Janna Saarela, M.D., Ph.D., Research Director of FIMM and Head of the FIMM Technology Center Genetics. Institute for Molecular Medicine, University of Helsinki, Finland

Sonia Sharma, Ph.D., Assistant Professor of Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California

Akiko Shimamura, M.D., Ph.D., Professor of Pediatrics, Director, Bone Marrow Failure and MDS Program,  Harvard Medical School, Dana-Farber and Boston Children’s Cancer 

Troy Torgerson, M.D., Ph.D., Associate Professor of Pediatrics, Director, Immunology Diagnostic Lab (IDL), and Co-Director, Non-Malignant Transplant Program, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington

Camilo Toro, M.D., Staff Clinician, Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health

Joris Van Montfrans, M.D., Ph.D., Staff Clinician, Pediatric Immunology, UMC Utrecht, Netherlands

Marcin Wlodarski, M.D., Ph.D., Assistant Faculty Member, Pediatric Hematology, St. Jude Children’s Research Hospital, Memphis, Tennessee

Andrey Zavialov Ph.D., Investigator, Immunology, Guangzhou Institute of Pediatrics and GuangzhouWomen's and Children Medical Center, Guangdong, China

Qing Zhou, Ph.D., Investigator, Clinical Molecular Genetics, Zhejiang University, Zhejiang, China